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Abstract
Background: Transplantation is the only treatment offering long-term benefit to patients with chronic kidney
failure. Live donor nephrectomy is performed on healthy individuals who do not receive direct therapeutic benefit
of the procedure themselves. In order to guarantee the donor’s safety, it is important to optimise the surgical
approach. Recently we demonstrated the benefit of laparoscopic nephrectomy experienced by the donor.
However, this method is characterised by higher in hospital costs, longer operating times and it requires a well-
trained surgeon. The hand-assisted retroperitoneoscopic technique may be an alternative to a complete
laparoscopic, transperitoneal approach. The peritoneum remains intact and the risk of visceral injuries is reduced.
Hand-assistance results in a faster procedure and a significantly reduced operating time. The feasibility of this
method has been demonstrated recently, but as to date there are no data available advocating the use of one
technique above the other.
Methods/design: The HARP-trial is a multi-centre randomised controlled, single-blind trial. The study compares the
hand-assisted retroperitoneoscopic approach with standard laparoscopic donor nephrectomy. The objective is to
determine the best approach for live donor nephrectomy to optimise donor’s safety and comfort while reducing
donation related costs.
Discussion: This study will contribute to the evidence on any benefits of hand-assisted retroperitoneoscopic versus
standard laparoscopic donor nephrectomy.
Trial Registration: Dutch Trial Register NTR1433
Background
Transplantation is the only treatment offering long-term
benefit to patients with chronic kidney failure. As the
number of patients suffering end stage renal disease
(ESRD) increases, the recruitment of more kidney
donors is important [1]. Live kidney donation is the
most realistic option to reduce donor shortage on short-
and long-term. Increasing the number of donors will
decrease the number of patients on the waiting list and
consequently reduce patient’s mortality. Implementation
of live donation offers the possibility to transplant
before the kidney disease reaches the terminal phase,
necessitating dialysis. Thus, this so called pre-emptive
transplantation may prevent unnecessary surgical inter-
ventions to establish dialysis (including costs and mor-
tality) and dialysis related complications. In the last
decade the number of non-related live kidney donations
is rising. Among these donors are family and friends of
the recipient, and even anonymous donors; the ethical
basis for live kidney donation is altering. The looser the
connection between the donor and recipient is, the less
clear the profit for the donor is.
Live donor nephrectomy is performed on healthy indi-
viduals who do not receive direct therapeutic benefit of
the procedure themselves. In order to guarantee safety
for the donors, it is important to optimise the surgical * Correspondence: l.dols@erasmusmc.nl
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laparoscopic nephrectomy (LDN) to the donor. How-
ever, this method is characterised by higher in-hospital
costs, longer operating times and requires a well-trained
surgeon [2]. The hand-assisted retroperitoneoscopic
technique (HARP-technique) may be an alternative to a
complete laparoscopic, transperitoneal approach. The
peritoneum remains intact and the risk of visceral inju-
ries is reduced. The hand-assistance results in a faster
procedure and a significantly reduced operating time
[3-7]. The feasibility of this method has been demon-
strated recently, but as to date studies advocating the
u s eo fo n et e c h n i q u ea b o v et h eo t h e ra r el a c k i n g .T h i s
randomised controlled trial compares the hand-assisted
retroperitoneal approach to the current standard, the
transperitoneal laparoscopic technique, to define the
most optimal approach.
We recently proved that laparoscopic kidney donation
is beneficial for the donor. In comparison to minimally
invasive open techniques, laparoscopic kidney donation
is associated with a better quality of life, less pain,
shorter in hospital stay and earlier return to work. This
method is expensive for the hospital, has a long operat-
ing time and requires an experienced, well-trained, sur-
geon [2,8,9]. Other studies showed a possibly increased
rate of life threatening complications, such as injuries to
the intestines and bleeding [10,11]. A surgical approach
that is easier to learn and applicable in the majority of
donors (i.e. selection of donors is not required) with
similar benefits as the transperitoneal laparoscopic
approach is warranted.
The hand-assisted retroperitoneoscopic approach may
be a viable alternative. With this method the surgeon
inserts his hand to create a retroperitoneal space, which
is thereafter insufflated with gas. The peritoneum stays
intact and tactile sensation remains. The chance of a
complication to the intestines is very small. Further-
more, this technique is easier and quicker to learn for
the surgeon than the laparoscopic approach. There is no
randomized controlled trial comparing both techniques
for the effectiveness [3-6].
Methods/Design
Study objective
To determine the best approach for live donor
nephrectomy i.e. to optimise donor’s safety and comfort
while reducing donation related costs.
Study design
The HARP-trial is a multi-centre, randomised con-
trolled, single-blind trial. We have stratified per centre.
The study started on July 24th 2008 and the duration of
the inclusion will be approximately 3 years. The study
compares hand-assisted retroperitoneoscopic donor
nephrectomy and standard laparoscopic donor nephrect-
omy. In total 190 live kidney donors will be included in
the study. Approval of the medical ethical committee of
both centres was obtained.
Randomisation will take place after endotracheal intu-
bation, by means of telephonic consultation of the study
coordinator. A computer generated randomisation list
with hidden block size is made for each centre by the sta-
tistician. The donor and the physicians involved in the
postoperative period are blinded to the surgical technique
until one year after donor nephrectomy. The operating
theatre is not accessible for people who do not join the
operating team. An independent surgeon evaluates
the donor on the outpatient clinic before operation. As the
extraction incision is similar in both techniques, we did
not attempt to cover the wounds with a standard pattern
of bandages [12]. All donors fill out the questionnaires
until one year after donation, the Short-form 36 (SF-36),
Euroqol (EQ-5D), Visual Analogue Scale (VAS) and a
questionnaire about work and homecare.
Patient selection
All, properly Dutch speaking, live kidney donors who
are medically capable of donating their left kidney can
be included in the HARP-trial. Informed consent is
mandatory. All types of live kidney donors can partici-
pate in the study, i.e. related, unrelated, altruistic and
cross-over live kidney donors.
Exclusion criteria are a history of kidney surgery or
adrenal gland surgery on the left side.
All potential donors are informed about the study at
the outpatient clinic. For further information the patient
can refer to the research fellow, transplant surgeon, or
the independent physician. If a patient does not sign the
informed consent form, the patient is not included in
the study and therefore will be operated via the standard
protocol. A live kidney donor can always withdraw his
or her consent at anytime during the study.
Hypothesis
The left-sided hand-assisted retroperitoneal approach
will lead, with a similar or better quality of life, to fewer
complications, and reduced operating times and costs.
Study Questions
Primary Question: Does left-sided hand-assisted retro-
peritoneoscopic donor nephrectomy lead to a similar or
better quality of life as compared to left-sided transperi-
toneal laparoscopic donor nephrectomy?
Secondary Question: Is the retroperitoneoscopic tech-
nique safer (conversions and complications) than the
transperitoneal technique?
Other secondary endpoints: pain perception, return to
work, operation time, cost-effectiveness from both a
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Pilot study
The Erasmus Medical Centre Rotterdam harbours one
of the largest European live kidney donor transplanta-
tion programs. On a yearly basis 75 to a 100 laparo-
scopic donor nephrectomies are performed. Our
strategy is to improve the results of live kidney donation
by optimizing the surgical technique with decreased
complication rates and costs. The infrastructure, raised
in earlier studies, led to the formation of a multidisci-
plinary team, with a high standard of care and surgery.
In the previous study on live kidney donation running
at our centre we compared the laparoscopic technique
to the mini-incision muscle-splitting technique [2].
Laparoscopic donor nephrectomy resulted in early
recovery, less fatigue and a better quality of life. How-
ever, the laparoscopic technique was more expensive
from a hospital point of view and demanded more
experience from the surgeon.
A pilot study with 60 live kidney donors showed the
feasibility of the retroperitoneal hand-assisted approach
[3]. Even in this small group operating time was signifi-
cantly reduced. It seems feasible to expand the surgical
armamentarium with this technique. However, we first
have to demonstrate similar or better quality of life in
comparison with the laparoscopic technique.
Surgical intervention
Both procedures were performed with the donor placed
in right-decubitus position. LDN was performed as
described earlier [8]. Shortly, a 10-mm trocar was intro-
duced under direct vision. The abdomen was insufflated
carbon dioxide to 12 cm H2Op r e s s u r e .A3 0 °v i d e o
endoscope and 3 to 4 additional trocars were intro-
duced. The colon was mobilized and displaced medially.
Opening of the renal capsule and division of the perire-
nal fat was facilitated using an ultrasonic device (Ultraci-
sion, Ethicon, Cincinnati, USA). After identification and
careful dissection of the ureter, the renal artery and the
renal vein, a pfannenstiel incision was made. An endo-
bag (Endocatch, US surgical, Norwalk, USA) was intro-
duced into the abdomen. The ureter was clipped distally
and divided. The renal artery and vein were divided
using an endoscopic stapler and the kidney was placed
in the endobag and extracted through the pfannenstiel
incision.
In HARP we started with a 7-10 cm pfannenstiel inci-
sion [3]. After blunt dissection to create a retroperito-
neal space, the Gelport (Applied Medical, Rancho Santa
Margarita, California, USA) was inserted. Blunt intro-
duction of the first trocar between the iliac crest and
the handport was guided by the operator’sh a n di n s i d e
the abdomen. CO2 was insufflated retroperitoneally to
12 cm H2O pressure. Two other 10-12 mm trocars,
respectively just outside the midline inferior to the
costal margin and in the flank, were inserted to create a
triangular shape. For dissection the aforementioned
ultrasonic device was used. Dissection of the kidney and
renal vessels was similar to transperitoneal donor
nephrectomy but with hand-assistance and from a
slightly different angle. The kidney was removed
manually.
Outcome measures
Primary outcome: Physical functioning as a measure for
quality of life one month after donor nephrectomy. This
is one of the dimensions of the standardized SF-36
questionnaire. Physical functioning is measured by
means of the complaints with daily physical activities,
like walking stairs, carrying grocery bags, walking 500
meter, etc. The SF-36 is in our opinion a suitable para-
meter to measure post-operative recovery [13].
Secondary outcome: Direct costs (costs for the hospi-
tal). Other secondary endpoints: conversion to open sur-
gery, complications, pain perception, work resumption,
other dimensions of quality of life (SF-36), cost-effec-
tiveness from hospital and health care perspective.
Costs-effectiveness
In this effectiveness analysis the effect of the surgical
procedure on quality of life of the donor and the costs
for the hospital are the most important outcome mea-
sures. The donor is the central point of interest; there-
fore we chose quality of life as primary endpoint for the
power calculation. Saving money, but with a worse qual-
ity of life for the donors is indeed not relevant.
Power calculation
A difference of 7.5 point in physical functioning (SF-36)
is a relevant difference. In international literature, a five
point difference is the minimal clinically relevant differ-
ence [13]. In our previous study, reviewers thought this
difference of five points was too small. Ten points is a
big difference, but in our previous study this difference
was observed after one month. A difference of 7.5 is in
the middle of these data. Physical functioning is
expressed on a scale of zero till hundred. Zero means a
very limited function and hundred means an unrest-
rained function. With a measured standard deviation of
18.4 points (reference for left-sided kidney donation in
the last five years), an alpha of 0.05, and a beta of 0.2,
95 donors have to be enrolled in both groups (Altman,
Practical statistics for medical research, Chapman&Hall/
CRC, 1991). Hereby we test two-sided, because the
hand-assisted technique could be similar or even better
than the laparoscopic technique. All data will be
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Costs and effectiveness will be combined with the Euro-
qol 5-D to express the difference between both techni-
ques in quality adjusted life years (QALYs).
Treatment of participating live kidney donors
The donor is prehydrated with intravenous crystalloids
before operation. On the morning of surgery antithrom-
botic stockings are given. The anaesthetist uses a stan-
dard protocol for live kidney donation anaesthesia
(remifentanyl and propofol), intravenous policy, and
respiration. One hour after the beginning of the opera-
tion, 20 mg mannitol is infused. During the operation
the research-fellow notes warm-ischemia time, blood
loss, and complications. Postoperative pain medication
is measured through a Patient Controlled Analgesic
(PCA; morphine) device. If the patient does not use the
PCA for 6 hours, the PCA is stopped. The dosage regi-
men is registered. Patients can be discharged when they
meet with the following criteria:
- The donor tolerates a normal diet
- The donor is mobile (is able to walk stairs)
- The donor is adequate and oriented
- The donor does not use intravenous medication
All live kidney donors will be seen at the outpatient
clinic after four weeks, three months and yearly there-
after. All donors are asked to fill out different question-
naires; we measure pain and nausea scores (VAS-score),
quality of life (SF-36, EQ-5D), and a questionnaire on
work and homecare (Table 1).
Unexpected events
The live kidney donor is informed at the outpatient
clinic on the background of the study, possible
complications and the chance of conversion to an open
approach. After both operations the donor may wake up
having an extra scar caudal to the costal margin if the
operation is converted to an open approach.
If a donor has post-operative pain or discomfort of the
bandages, they can be removed. All documentation will
be marked with the HARP-trial logo. Information about
the operation technique will be sealed in an envelope in
the medical file. In case of unexpected events this envel-
ope may be opened. Unexpected events are reported to
the responsible physician and the study coordinator.
Access to personal data
All personal data are coded into numbers (1 to 190).
The coordinating investigator and the principle investi-
gator are the only ones who have access to the coding
system. All data are imported in a database, which is
managed by the coordinating investigator. At the end of
the trial all data are analysed together with the trial
statistician.
Discussion
The hand-assisted retroperitoneoscopic technique may
be an alternative to a complete laparoscopic, transperi-
toneal approach. The feasibility of this method has been
demonstrated recently, but as to date there are limited
data available advocating the use of one technique above
the other [3-7]. This randomised controlled trial com-
pares the hand-assisted retroperitoneal approach to the
current standard, the transperitoneal laparoscopic tech-
nique to define the most optimal approach.
In comparison to minimally invasive open techniques,
laparoscopic kidney donation is associated with a better
quality of life, less pain, shorter in-hospital stay and ear-
lier return to work. This method is time consuming,
leading to high hospital costs, and requires an experi-
enced surgeon. Other studies showed a possibly
increased rate of major, life threatening, complications,
such as injuries to the intestines and bleeding [10].
The hand-assisted retroperitoneoscopic approach may
be a viable alternative. The chance of a complication to
the intestines is very small, and hand-assistance could
be beneficial for the control of bleedings. There is no
randomized controlled trial comparing both techniques.
Only three small studies compare left-sided hand-
assisted retroperitoneoscopic with laparoscopic donor
nephrectomy, but only with respect to clinical para-
meters [3-5,7]. Wadstrom et al compared the LDN (n =
11), hand-assisted laparoscopic technique (HALS) (n =
14), and the HARP (n = 18). The operation time with
the HARP was significantly shorter than the LDN
(141 vs. 270 min, p < 0.01) [7]. Sundqvist et al per-
formed a prospective study, comparing HARP (n= 11),
LDN (n= 14) and open donor nephrectomy (n= 11).
Table 1 Time schedule for filling out the questionnaires
Time of evaluation VAS EuroQol SF-36 Work and homecare
Preoperative XX X X
Postoperative
Day 0 X
Day 1 X
Day 2 X
Day 3 XX
Week 1 XX X
Week 2 XX X
Week 4 XX X
Week 6 XX
Week 8 XX
Month 3 XX X
Month 6 XX X
Month 12 XX X
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had a significantly shorter operation time compared to
LDN (145 min vs 218 min, p < 0.05) [5]. Gjertsen et al
performed a retrospective study, comparing HARP
(n = 11), LDN (n= 15) and open donor nephrectomy
(n= 25). Reduced operation time was observed for the
HARP group compared with the LDN (166 min vs 244
min) [4]. Dols et al performed a prospective study, compar-
ing 20 left-sided HARP procedures and 40 left-sided LDNs.
Median operation time and WIT were shorter in HARP
( 1 8 0v s .2 2 5m i n ,p=0 . 0 0 2a n d3v s .5m i n ,p=0 . 0 0 7
respectively) [3].
All other studies only described surgical outcome, and
did not address quality of life of live kidney donors. Our
main point of interest is to know whether the donors
operated on with the hand-assisted retroperitoneal tech-
n i q u eh a v eag o o dq u a l i t yo fl i f ea f t e r w a r d s .T h e r e f o r e
we will perform this randomised controlled trial com-
paring laparoscopic to hand-assisted retroperitoneo-
scopic technique, with physical function as a primary
outcome.
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